Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.
about
Enhancement of CCL2 expression and monocyte migration by CCN1 in osteoblasts through inhibiting miR-518a-5p: implication of rheumatoid arthritis therapy.The Comparison of Adipose Stem Cell and Placental Stem Cell in Secretion Characteristics and in Facial Antiaging.Role of microRNA-26a in the diagnosis of lower extremity deep vein thrombosis in patients with bone trauma.
P2860
Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Diallyl disulfide inhibits TNF ...... /ERK and NF-Kappa-B signaling.
@ast
Diallyl disulfide inhibits TNF ...... /ERK and NF-Kappa-B signaling.
@en
type
label
Diallyl disulfide inhibits TNF ...... /ERK and NF-Kappa-B signaling.
@ast
Diallyl disulfide inhibits TNF ...... /ERK and NF-Kappa-B signaling.
@en
prefLabel
Diallyl disulfide inhibits TNF ...... /ERK and NF-Kappa-B signaling.
@ast
Diallyl disulfide inhibits TNF ...... /ERK and NF-Kappa-B signaling.
@en
P2093
P2860
P1433
P1476
Diallyl disulfide inhibits TNF ...... /ERK and NF-Kappa-B signaling.
@en
P2093
H Flores-Rozas
J S Reuben
K F A Soliman
S Darling-Reed
S Sadrud-Din
P2860
P304
P356
10.1016/J.CYTO.2014.12.007
P577
2015-06-19T00:00:00Z